Patent assignee · FR · COMPANY

IMCHECK THERAPEUTICS SAS

4Patents
4Active
4Granted
41Portfolio score

Filing activity: Sep 21, 2018 → Jun 1, 2023

Most-cited patents

PatentTitleAreaCited byStatus
US12247075B2 BTN3A binding proteins and uses thereof Chemistry; Metallurgy 0 Active
US11572409B2 Antibodies having specificity for BTN2 and uses thereof Chemistry; Metallurgy 0 Active
US12258400B2 Antibodies having specificity for BTN2 and uses thereof Chemistry; Metallurgy 0 Active
US11945871B2 Anti-BTN3A antibodies and their use in treating cancer or infectious disorders Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.